Scott McKeown was quoted by IPWatchdog in an article titled, “Who Will it Be? IP Practitioners Name Their Picks for Biden CAFC Appointee Following Judge Wallach’s Retirement.” In this article, Scott j...
John Welch was quoted by Bloomberg Law in an article titled “4th Cir. Clears Two Paths for Repeat Trademark Ruling Reviews.” Read more.
PTAB Wolf Greenfield is among five firms that are finalists in the national “PTAB” category and Rich Giunta, chair of the firm’s Post-Grant Proceedings Practice, is among seven finalists in the “Pract...
Scott McKeown was quoted in a Law360 article titled, “These Firms Landed The Most PTAB Work In 2020.” In this article, Scott discussed the busiest patent law firms in 2020. Read more (subscription req...
In an interview titled “Combining a Career in Science and Law” featured on the Boston College Career Center Blog, Kevin MacDonald shares his insights on working at the intersection of science and law....
Scott McKeown was quoted by Intellectual Asset Management in an article titled, “The changing PTAB playbook means long-neglected re-exams might be making a comeback.” In this article, Scott discussed ...
Wolf Greenfield is proud to partner with the Foundation for Advancement of Diversity in IP Law (FADIPL) to advance diversity in the intellectual property law profession. Together, Wolf Greenfield and ...
Dan Rudoy was quoted by InformationWeek in an article titled “What Lawyers Want Everyone to Know About AI Liability.” Read more.
Wolf Greenfield has been ranked as one of only two law firms in the gold category in Massachusetts and attorneys received national individual recognition in the World Trademark Review 1000 – The World...
Patexia’s Patent Litigation Intelligence Report has named Wolf Greenfield among the best performing and most active law firms for patent litigation.
John Van Amsterdam, shareholder in Wolf Greenfield’s Biotechnology Practice and Chair of the firm’s Hiring Committee, was featured on the American Bar Association’s (ABA) Legal Rebels Podcast. John ta...
Jonathan Roses was quoted by Bloomberg Law in an article titled “PTAB Sees Fewer Drug Patent Fights as Generics’ Strategy Shifts.” Read more.